Gleb is a member of the firm’s Biotechnology/Chemical/Pharmaceutical Practice Group. His practice includes drafting and prosecuting patent applications in biotechnology, pharmaceutical and chemical fields, including treatment of cancer and other diseases, biologics and small molecule drugs, nucleic acid and peptide sequences, probiotics, polymers, lithium-ion batteries, and alloys. Gleb’s practice also includes rendering opinions on patentability, infringement, and validity.